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Abstract. The reactivity of islet cell cytoplasmic antibod- 
ies (ICA)-positive and ICA-negative sera of recent onset 
type 1 diabetic patients was studied in human fetal pan- 
creata of 12-18 weeks' gestation and compared with the 
reactivity of these sera in adult human control pancreata. 
The aims of the study were: (1) to observe the presence of 
ICA staining in human fetal islet cells; (2) to compare 
endpoint titres (in Juvenile Diabetes Foundation units) of 
ICA-positive patient sera in fetal pancreata nd adult 
human control pancreata. Ten ICA-positive sera and 
eight ICA-negative sera from newly diagnosed iabetic 
patients and four sera from healthy controls were tested 
on three human adult and eight human fetal pancreata. 
As in the adult control pancreata. ICA-positive sera re- 
acted to insulin-, glucagon-, and somatostatin-positive 
cells of fetal pancreata of all gestational ages. This was 
observed both in single cells and in cells in islet-like cell 
clusters. Dilution of a reference serum gave similar results 
in both adult and fetal pancreata. In contrast, the ICA- 
positive patient sera yielded a striking heterogeneity in 
fetal as well as in adult pancreata. However, end-point 
titres between adult and fetal pancreata did not differ 
significantly (P > 0.05). In conclusion, ICA-positive sera 
from recent onset diabetic patients how that the expres- 
sion of molecules to which ICA react is present in all islet 
cells and starts before week 12 of gestation. 
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Introduction 
Humoral autoimmunity to pancreatic islet cells can be 
detected in sera of recent-onset type I (insulin-depen- 
dent) diabetic patients and in sera of prediabetic ndivid- 
uals before clinical onset of type 1 diabetes [1]. Islet cell 
cytoplasmic antibodies (ICA) have been studied exten- 
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sively. They are detected by indirect immunofluorescence 
of cryostat sections of blood group 0 human adult pan- 
creata. ICA-positive sera usually stain c~,/~, and 6 cells in 
the islets of Langerhans ("whole islet staining pattern") 
[2]. The assay has been standardized through the use of 
reference sera [3]. Multiple islet cell antigens have been 
suggested as ICA targets including glutamic acid decar- 
boxylase (GAD) [4-6]. Apart from the whole islet stain- 
ing pattern of ICA-positive sera, a restricted pattern, in 
which only fl cells are stained, has been observed [7]. 
In experimental studies it has been shown that the 
onset of autoimmunity depends on the timing of antigen 
expression during fetal development [8]. It is therefore of 
interest o study human fetal antigen expression, using 
ICA-positive patient sera. Limited information is avail- 
able on the reactivity of ICA to human fetal pancreatic 
tissue [9]. This tissue contains endocrine cells at various 
stages of development, being present as single cells or 
organized in smaller or larger endocrine cell clusters [101. 
In one study a single ICA-positive serum and a single 
ICA-negative serum were tested [9]. Only insulin/ICA 
double-staining was evaluated. The other endocrine cell 
types were not analyzed. No comparison was made with 
adult pancreata. In the present study, the ICA staining 
pattern in all major islet cell types was investigated. End- 
point titres [in Juvenile Diabetes Foundation (JDF) 
units] of a series of ICA-positive sera were determined in
fetal and adult control pancreata. 
Materials and methods 
Sera. Serum samples were obtain within 24 h of the first insulin 
injection from 18 type 1 diabetic patients (aged 8-20 years, mean 
14 years; four boys and six girls). The ICA-positive samples (n = 10) 
were selected to represent a range from weakly to strongly positive 
for ICA, as tested with an adult pancreas. The cut-off point for the 
distinction between an ICA-positive and an ICA-negative patient 
serum was 0.63 JDF unit. All sera were ICA-IgG positive, and six 
showed complement fixation abiiity (CF-ICA) [i 1]. Insulin autoan- 
tibodies (IAA) in these samples were absent according to radioim- 
munoassay, RIA [12], as well as enzyme-linked immunosorbent 
assay, ELISA [13]. Control sera were obtained from four healthy 
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individuals. No control had a first-degree relative with insulin de- 
pendency. Serum samples were stored at -80 ~ 
Human fetal pancreata. Human fetal pancreata (blood group 0) 
between 12 and 18 weeks gestation (n = 8) were obtained from me- 
chanical abortion, approved by the local ethical committee, and 
with signed informed consent. The warm ischemia time was less 
than 20 rain. After collection, the pancreata were snap-frozen i  
liquid nitrogen and stored at -80~ Blood group typing was 
performed on spleen cells. 
Human adult pancreata. Blood group 0 pancreata were obtained 
from three donors. The pancreas was removed first. The adult 
pancreata were divided into pieces of 0.5 cm 3, snap-frozen i liquid 
nitrogen, and stored at -80 ~ 
Immunohistochemistry. The methods used have been described pre- 
viously [14, 15]. Briefly, cryostat sections were incubated for 18 h 
with serum (diluted 1:2 to 1:1024) in phosphate-buffered saline 
(PBS). Aprotinin (Trasylol, Sigma Chemical Co., St. Louis) 
0.47 mg/ml was added to prevent proteolytic degradation of the 
pancreatic tissue. Incubations were performed in a dark-moist 
chamber at room temperature. Slides were washed in PBS, and 
double staining was carried out with a mouse anti-human proin- 
sulin monoclonal antibody (GS4G9, dilution 1:10, a gift of Dr. 
O.D. Madsen, Gentofte, Denmark) for 30 rain. Slides were again 
washed in PBS, and the sections were incubated with a TRITC-la- 
belled rabbit anti-mouse IgG 1:100 (PBS) (Dako, Copenhagen, 
Denmark) for 30 rain. Finally, fluorescein isothioeyanate (FITC)- 
conjugated rabbit anti-human IgG (Dako) was added in a dilution 
of 1 : 100 for 30 rain, to detect ICA. Antibodies to glucagon (GLU- 
001, 1:30, Novo, Bagsvaerd, Denmark) or somatostatin (SOM-018, 
1 : 1000, Novo) were used for double staining instead of the proin- 
sulin antibody to detect he other endocrine cell types. Both were 
mouse monoclonal ntibodies. 
Sera were diluted stepwise, until reciprocal titers of 1024, gener- 
ating 10-point titration curves. The reciprocal endpoint itre was 
defined as the maximal dilution at which fluorescence could be 
detected by two independent observers. A reference serum (80 JDF 
units/ml) was used on all pancreata studied (three adult, eight fetal), 
by diluting to four different concentrations (1:2, 1:8, 1:32, and 
1 : 128) in normal ICA-negative serum [3J. These four concentrations 
were further diluted to obtain final reciprocal titers between 1:4 and 
1:16 384. Linear titration curves were obtained. The limited amount 
of fetal tissue available and the unknown sensitivity of these pancre- 
ata for the ICA sera were reasons to deviate from ICA workshop 
recommendations. Transformation from endpoint titre to JDF 
units was based on reciprocal endpoint titre of the reference serum 
on each pancreas. 
Table 1. Reciprocal endpoint titres and transformation into JDF units 
adult and eight fetal human pancreata 
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Statistical analysis. Differences in endpoint titre between adult and 
fetal pancreata were analyzed by the Mann-Whitney U-test. 
Resu l ts  
We have previously described the histologic features of  
the human midgestational pancreas using antibodies to 
insulin, glucagon, and somatostatin [10]. In accordance 
with that study, positive single cells and cell clusters of  
varying sizes were observed for all three hormones tested 
and in all eight fetal pancreata used for this study. 
Reciprocal endpoint titres and corresponding JDF  
units of  ICA  for the adult and fetal pancreata re indicat- 
ed in Table 1. In three fetal pancreata (F1, F2, F6), the 
limited amount  of  tissue prohibited the testing of  some of 
the sera. In pancreata F2, F3, F7, and F8, one ICA-pos-  
itive serum did not react, whereas in pancreas F1, two 
sera did not react (see Table 1). In the adult pancreata, 
two sera did not react to pancreas A3, whereas all sera 
showed ICA staining on the other two adults pancreata. 
Double staining of  sections, combining ICA  sera with 
antibodies to insulin, glucagon, and somatostatin, 
showed that all three cell types express ICA targets 
(Fig. 1). In addition to ICA-reactive endocrine cell clus- 
ters, single-hormone-containing cells were also stained 
(Fig. 2). In all pancreata nd with all ICA-posit ive sera, 
the "whole islet staining pattern" was observed [2], 
whereas/?-cell-restricted ICA staining was not seen in this 
study. No  hormone-negative c lls reacted with ICA-pos-  
itive sera in either the fetal or adult pancreata. 
The results of  testing and titrating the reference serum 
and its dilutions are shown in Table 2. All three adult 
pancreata had identical reciprocal endpoint titres. The 
endpoint titre of  the reference serum in fetal pancreata 
F1, F4, and F5 was one dilution step lower, whereas the 
difference was two steps in pancreata F7 and F8. The 
results of  the 10 patient sera were highly heterogeneous, 
for the three adult as well as the eight fetal pancreata~ 
With sera 6, 7, and 10, pancreas A1 showed titres which 
were 5, 4, and 4 dilution steps lower than for the same 
sera with pancreas A2, respectively. With sera 3, 4, 8, and 
(in parentheses) of 10 sera of recent-onset diabetic patients for three 
Pancreas Serum number 
(weeks of 
gestation) 1 2 3 4 5 6 7 8 9 10 
A1 4 (1.25) 4 (1.25) 8 (2.5) 16 (5) 4 (1.25) 32 (10) 8 (2.5) 32 (10) 256 (80) 
A2 16 (5) 16 (5) 4 (1.25) 64 (20) 16 (5) 1024 (320) 128 (40) 32 (10) 256 (80) 
A3 0 (0) 0 (0) 2 (0.63) 64 (20) 8 (2.5) 512 (160) 128 (40) 8 (2.5) 32 (10) 
F1 (12) 0 (0) 0 (0) NT 8 (2.5) 8 (2.5) NT 8 (10) NT NT 
F2 (13) 0 (0) NT 4 (1.25) 16 (5) NT 256 (80) 16 (5) 2 (0.63) 4 (1.25) 
F3 (13) 2 (0.63) 2 (0.63) 8 (2.5) 16 (5) 16 (5) 256 (80) 4 (1.25) 8 (2.5) 128 (40) 
F4 (13) 8 (2.5) 8 (2.5) 8 (2.5) 32 (10) 8 (2.5) 128 (40) 16 (5) 4 (1.25) 64 (20) 
F5 (14) 4 (1.25) 8 (2.5) 8 (2.5) 64 (20) 4 (1.25) 128 (40) 64 (20) 32 (10) 128 (40) 
F6 (14) 8 (2,5) 8 (2.5) 16 (5) 32 (10) 16 (5) NT NT NT NT 
F7 (15) 0 (0) 8 (2.5) 4 (1.25) 16 (5) 8 (2.5) 128 (40) 32 (10) 4 (1.25) 64 (20) 
F8 (17) 8 (2.5) 8 (2.5) 4 (1.25) 32 (10) 8 (2.5) 128 (40) 32 (10) 16 (5) 64 (20) 
8 (2.5) 
128 (40) 
32 (10) 
NT 
16 (5) 
0 (0) 
32 (10) 
16 (5) 
NT 
2 (0.63) 
0 (0) 
0, Negative; N~I, not tested; A, adult pancreas; F, fetal pancreas (gestational age in weeks indicated in brackets) 
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Fig. 1 a, b. Immunofluorescence photographs of an identical area 
in a human fetal pancreatic section double-stained with an ICA- 
positive serum (a) and with a monodonal proinsulin antibody (b). 
Note that ICA reactivity is present in cells surrounding the proin- 
sulin-positive cell core 
Fig. 2a, b. Immunofluorescence photographs of an identical area 
in a human fetal pancreatic section double-stained with an ICA- 
positive serum (a) and with a monoclonal proinsulin antibody (b). 
Co-expression of proinsulin and ICA reactivity can be observed in 
a single ndocrine cell 
Table 2. Reciprocal endpoint titres of the reference serum for adult 
(A) and fetal (F) pancreata 
Pancreas Reference 
(weeks of serum 
gestation) 
Reference serum dilution 
1:2 1:8 1:32 1:128 
AI 256 128 32 8 2 
A2 256 128 32 8 2 
A3 256 128 32 8 2 
F1 (12) 64 32 8 2 0 
F2 (13) 256 128 32 32 8 
F3 (13) 256 128 32 8 2 
F4 (13) 64 32 8 2 2 
F5 (14) 64 32 8 2 2 
F6 (14) 256 128 32 2 2 
F7 (15) 16 8 2 2 0 
F8 (17) 16 8 2 2 0 
9, however, titres were similar or even 1 or 2 dilution steps 
higher. Serum 9 gave a 5-dilution-steps lower titre in pan- 
creas F2 than in pancreas F3, whereas with serum 7, 
pancreas F2 had a two-step higher titre. No  significant 
differences in endpoint itre between adult and fetal pan- 
creata could be detected (P>0.05) .  
Of  the eight sera of  recent-onset diabetic patients 
which tested ICA-negative on adult pancreata, two were 
found reactive to pancreas F3 and F5, one other serum 
reacted to pancreas F6, all at a dilution of  1:2 (0.63 JDF  
units). None of  the four healthy control sera reacted to 
either adult or fetal pancreata. 
Discussion 
We confirm the observation of  Sundkvist et al. [9] that 
ICA  reactivity is present in the human fetal pancreas. 
ICA  reactivity is found in all fetal pancreata between 12 
and 18 weeks' gestation, indicating that expression of  
molecules to which ICA react starts before week 12 of 
gestation. The ICA  reactivity includes all insulin-, 
glucagon-, as well as somatostatin-positive cells, consis- 
tent with findings in the adult pancreas [16]. In this study, 
no /%cell-restricted ICA  reactivity pattern is found. In 
human fetal pancreata, ICA  reactivity is seen in en- 
docrine cell clusters and in single-hormone-containing 
cells. Thus, ICA  reactivity does not mark the different 
stages of  endocrine cell development during the 12-18-  
week period. This is supported by the finding that the 
staining pattern is quite similar in the different fetal pan- 
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creata. We have not examined hormone co-expressing 
cells in which two or three hormones are present simulta- 
neously, as shown to be present during endocrine cell 
ontogeny [10]. Triple labelling studies should be used to 
analyze whether or not the multiple-hormone-expressing 
cells also exhibit ICA reactivity. Analysis of reference 
serum reactivity on adult pancreata gives an identical 
result at each dilution in each of the three pancreata. 
When our 10 diabetic sera are applied, however, hetero- 
geneous endpoint itres and corresponding JDF units are 
obtained. This variability in adult pancreata has been 
described before [17]. 
In the fetal pancreata, dilution of the reference serum 
yields endpoint titres comparable to those of the adult 
pancreata. Heterogeneous results are obtained in the fetal 
pancreata with the patient sera. This does not lead to 
significant differences in endpoint titres between adult 
and fetal pancreata. The differences in reactivity of ICA- 
positive sera between fetal pancreata may be explained by 
the fact that ICA react to multiple target molecules which 
are not present in equal amounts during development 
[7, 18]. During fetal development, islet cells are present at 
differing developmental stages, which may affect the 
antigenic profile qualitatively and quantitatively. In addi- 
tion, the metabolic state of endocrine cells, which is un- 
known in our fetal islet cells, has been shown to influence 
antigen expression [19]. No conclusion can be drawn with 
regard to the effect of antigenic heterogeneity in fetal 
pancreata on ICA titre, because this study did not ad- 
dress ICA reactivity to defined antigens. Further molecu- 
lar identification o f ICA  epitopes in the human fetal pan- 
creas is essential. 
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